
159.15 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 95.02 Today|||52-Week Range 159.74 | +17.59% Year-to-Date |
The 23 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 156.00, with a high estimate of 179.08 and a low estimate of 97.56. The median estimate represents a -1.98% decrease from the last price of 159.15.
The current consensus among 27 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.